Website: SynOx Therapeutics
Business Area(s):
Description:
SynOx is a clinical stage biopharmaceutical company. It is a spin out from Celleron Therapeutics Ltd, an oncology company focused on the clinical development of therapies to treat cancer. SynOx is developing emactuzumab, a CSF1R targeted therapeutic antibody designed to target and deplete tumour-associated macrophages in the tumour tissue.
Location(s):
Dublin
Ireland
See map: Google Maps